Hypertension Diagnostics (Hypertension Diagnostics) Total Stockholders Equity : $-4.75 Mil (As of Sep. 2019)

View and export this data going back to 1998. Start your Free Trial

What is Hypertension Diagnostics Total Stockholders Equity?

Hypertension Diagnostics's Total Stockholders Equity for the quarter that ended in Sep. 2019 was $-4.75 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hypertension Diagnostics's Book Value per Share for the quarter that ended in Sep. 2019 was $-0.09. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hypertension Diagnostics's Debt-to-Equity for the quarter that ended in Sep. 2019 was -0.99.

Hypertension Diagnostics Total Stockholders Equity Historical Data

The historical data trend for Hypertension Diagnostics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypertension Diagnostics Total Stockholders Equity Chart

Hypertension Diagnostics Annual Data

Trend

Jun06

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Dec16

Dec17

Dec18

Total Stockholders Equity

Get a 7-Day Free Trial

0.42

-0.29

-4.26

-4.63

-4.75

Hypertension Diagnostics Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19
Total Stockholders Equity	Get a 7-Day Free Trial															-4.63	-4.75	-4.75	-4.75	-4.75

Hypertension Diagnostics (OTCPK:HDII) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hypertension Diagnostics's Book Value per Share for the quarter that ended in Sep. 2019 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-4.752	-	0.006)	/	52.3887
	=	-0.09

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hypertension Diagnostics's Debt-to-Equity for the quarter that ended in Sep. 2019 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	4.685)	/	-4.752
	=	-0.99

Hypertension Diagnostics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hypertension Diagnostics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.